Bilateral ovarian metastasis of non-small cell lung cancer with ALK rearrangement-Reference-Cited by-同舟云学术

Bilateral ovarian metastasis of non-small cell lung cancer with ALK rearrangement

Published:2014-02 Issue:2 Volume:83 Page:302-304
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Fujiwara Ayako,Higashiyama Masahiko,Kanou Takashi,Tokunaga Toshiteru,Okami Jiro,Kodama Ken,Nishino Kazumi,Tomita Yasuhiko,Okamoto Isamu

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference5 articles.

1. Crizotinib versus chemotherapy in advanced ALK-positive lung cancer;Shaw;N Engl J Med,2013

2. ALK gene rearrangements: a new therapeutic target in a molecularly defined subset of non-small cell lung cancer;Solomon;J Thorac Oncol,2009

3. Lung carcinoma metastatic to the ovary: a clinicopathologic study of 32 cases emphasizing their morphologic spectrum and problems in differential diagnosis;Irving;Am J Surg Pathol,2005

4. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer;Soda;Nature,2007

5. Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression;Zhang;Mol Cancer,2010

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lung adenocarcinoma metastatic to the ovary: a retrospective clinicopathological analysis of 17 cases and literature review;Pathology;2024-07

2. Ovarian metastatic lung adenocarcinoma： a retrospective clinicopathological analysis of a consecutive 10-year case series;2023-10-09

3. Rare giant ovarian metastasis arising from a small primary lung adenocarcinoma: a case report;Frontiers in Surgery;2023-09-12

4. Serum procalcitonin as a tumor marker in lung adenocarcinoma with ovarian metastasis: a case report;Annals of Medicine & Surgery;2023-06-20

5. Ovarian metastases from ALK-positive lung adenocarcinoma: a case report and review of the literature;Translational Cancer Research;2022-09